Results 31 to 40 of about 7,568,653 (278)

Elevated endotoxin levels in non-alcoholic fatty liver disease [PDF]

open access: yes, 2010
Background: Emerging data indicate that gut-derived endotoxin may contribute to low-grade systemic inflammation in insulin resistant states. This study aimed to examine the importance of serum endotoxin and inflammatory markers in non-alcoholic fatty ...
Ashour, E.   +70 more
core   +1 more source

Treatments for NAFLD [PDF]

open access: yesFarmacja Polska, 2021
Non-alcoholic fatty liver disease (NAFLD) is categorised into simple steatosis, termed nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH).
Katarzyna Juszczyńska
doaj   +1 more source

Nonalcoholic fatty liver disease

open access: yesBest Practice & Research Clinical Gastroenterology, 2010
Non-alcoholic fatty liver disease (NAFLD), the most common liver disorder in the Western world, is a clinico-histopathological entity in which excessive triglyceride accumulation in the liver occurs. Non-alcoholic steatohepatitis (NASH) represents the necroinflammatory form, which can lead to advanced liver fibrosis, cirrhosis, and hepatocellular ...
KRAWCZYK M   +2 more
  +7 more sources

Nonalcoholic Fatty Liver Disease in Children: a Modern View on the Diagnosis and Treatment (II Part)

open access: yesGastroenterologìa, 2015
In Part II methods of research and treatment of nonalcoholic fatty liver disease in children are highlighted, which are based on the evidence. Ultrasound examination of the liver is the most common method for diagnosis of nonalcoholic fatty liver disease
Y.M. Stepanov   +3 more
doaj   +1 more source

Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?

open access: yesArchives of Endocrinology and Metabolism, 2019
Objective: Nonalcoholic fatty liver disease is the commonest diffuse liver disease, of which women with polycystic ovary syndrome are at an increased risk.
Na Di   +8 more
doaj   +1 more source

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease : a systematic review [PDF]

open access: yes, 2011
Non-alcoholic fatty liver disease (NAFLD) is closely linked with obesity and the prevalence of NAFLD is about 17% to 33% in the Western world. There is a strong association of NAFLD with insulin resistance and, hence, insulin sensitisers have been tried.
C Clar   +21 more
core   +1 more source

Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)

open access: yes, 2021
Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent metabolic chronic liver diseases in developed countries and puts the populations at risk of progression to liver necroinflammation, fibrosis, cirrhosis, and hepatocellular ...
Grattagliano I   +15 more
core   +1 more source

Association between the gut microbiota and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study

open access: yes, 2023
BACKGROUND: Increasing studies have shown that there is a significant association between gut microbiota and non-alcoholic fatty liver disease. AIMS: To show the potential association between gut microbiota and non-alcoholic fatty liver disease, we ...
Li, Yu   +23 more
core   +1 more source

Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis [PDF]

open access: yesТерапевтический архив, 2019
Aim. Сomparative studying of changes in the spectrum of bile acids in bile in patients with nonalcoholic fatty liver disease and cholelithiasis. Materials and methods.
Ya M Vakhrushev   +3 more
doaj   +1 more source

The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases [PDF]

open access: yes, 2014
A complex interaction among metabolic factors, adipose tissue lipolysis, oxidative stress, and insulin resistance results in a deleterious process that may link nonalcoholic fatty liver disease (NAFLD) with severe cardiovascular (CV) outcomes.
Poynard, Thierry   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy